GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting and FACs | NA | 0.4 | 0.684 | 33924995
|
ALDH1A1 | 402 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by ALDEFLUOR assay | NA | 0.4 | 0.684 | 29073729
|
DCLK1 | 2700 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting and FACs | NA | 0.4 | 0.0159 | 33924995
|
PROM1 | 9454 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting and FACs | NA | 0.4 | 0.7582 | 33924995
|
HES1 | 5192 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0095 | 33924995
|
HEY1 | 4880 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0021 | 33924995
|
JAG1 | 6188 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0117 | 33924995
|
NFKB1 | 7794 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0064 | 29073729
|
NOTCH1 | 7881 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0477 | 33924995
|
IL6 | 6018 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by qPCR | NA | 0.2 | 0.0191 | 29073729
|
IL8 | 6025 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | SFA followed by qPCR | NA | 0.2 | 0.0159 | 29073729
|
CD24 | 1645 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | FACs followed by SFA | NA | 0.12 | 0.456 | 29249690
|
CD44 | 1681 | LTM | Triple Negative Breast Cancer | Carcinoma | BT-20 | NA | FACs followed by SFA | NA | 0.12 | 1 | 29249690
|